A cost-effectiveness analysis of Maraviroc in treatment-experienced HIV patients in Scotland

Journal of the International AIDS Society - Tập 11 - Trang 1-1 - 2008
I Lekander1, J Berg1, A Christie2, C Leen3, M Nelson
1I3 Innovus, Stockholm, Sweden
2Pfizer Inc., Walton Oaks, UK
3Western General Hospital, Edinburgh, UK

Tài liệu tham khảo

Chancellor J, et al: A microsimulation of the cost-effectiveness of maraviroc for antiretroviral treatment-experienced HIV-infected individuals. ISPOR 13th Annual International Meeting. Toronto, Canada, 3–7. 2008, May : Presentation IN3